These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 2368229

  • 1. Distribution of skeletal metastases in prostatic and lung cancer. Mechanisms of skeletal metastases.
    Morgan JW, Adcock KA, Donohue RE.
    Urology; 1990 Jul; 36(1):31-4. PubMed ID: 2368229
    [Abstract] [Full Text] [Related]

  • 2. Metastatic prostatic pulmonary nodules with normal bone image.
    Petras AF, Wollett FC.
    J Nucl Med; 1983 Nov; 24(11):1026-7. PubMed ID: 6226768
    [Abstract] [Full Text] [Related]

  • 3. Optimizing the performance and interpretation of bone scans.
    Muroff LR.
    Clin Nucl Med; 1981 Oct; 6(10S):P68-76. PubMed ID: 6271444
    [No Abstract] [Full Text] [Related]

  • 4. Misleading renal stasis on bone scintigraphy in diffuse symmetrical skeletal metastases of prostatic carcinoma.
    Kalin B, Jacobsson H.
    Rofo; 1987 Oct; 147(4):465-6. PubMed ID: 2825278
    [No Abstract] [Full Text] [Related]

  • 5. [Local bone pain and osseous scintigraphic findings in patients with metastatic bone tumor].
    Imaeda T, Iinuma G, Hirota K, Inoue A, Sone Y, Seki M, Suzuki M, Doi H.
    Kaku Igaku; 1988 Dec; 25(12):1319-27. PubMed ID: 3249457
    [No Abstract] [Full Text] [Related]

  • 6. Clinical evaluation of a technetium-99m bone imaging agent based on the vicinal diphosphonate 1,2-diphosphonoethyleneglycol (DPEG).
    Pauwels EK, Camps JA, Blom J, Hermans J, Kelly JD, Cumming SA, Blackburn GM, Rashid A.
    Nucl Med Commun; 1985 Nov; 6(11):739-45. PubMed ID: 3831848
    [Abstract] [Full Text] [Related]

  • 7. Improved lesion detection with dimethyl-amino-diphosphonate: a report of two cases.
    Smith ML, Martin W, McKillop JH, Fogelman I.
    Eur J Nucl Med; 1984 Nov; 9(11):519-20. PubMed ID: 6240401
    [Abstract] [Full Text] [Related]

  • 8. Paget's disease mimicing skeletal metastases in a patient with coexisting prostatic carcinoma.
    Shih WJ, Riley C, Magoun S, Ryo UY.
    Eur J Nucl Med; 1988 Nov; 14(7-8):422-3. PubMed ID: 3181194
    [Abstract] [Full Text] [Related]

  • 9. 99mTc-MDP bone scintigraphy and 18F-FDG positron emission tomography in lung and prostate cancer patients: different affinity between lytic and sclerotic bone metastases.
    Garcia JR, Simo M, Perez G, Soler M, Lopez S, Setoain X, Lomeña F.
    Eur J Nucl Med Mol Imaging; 2003 Dec; 30(12):1714. PubMed ID: 14625662
    [No Abstract] [Full Text] [Related]

  • 10. [Patterns of bone metastases of carcinoma of the prostate: evaluation using 99mTC-MDP bone scintigraphy].
    Matsuda H, Sakashita S, Arakawa M, Koyanagi T.
    Nihon Hinyokika Gakkai Zasshi; 1987 Oct; 78(10):1809-13. PubMed ID: 3444173
    [No Abstract] [Full Text] [Related]

  • 11. Quantitative bone scan and bone metastases in prostatic cancer.
    Grob JC, Thiel J, Méthlin G, Wolf P, Bollack C.
    Urol Int; 1985 Oct; 40(1):45-7. PubMed ID: 3156441
    [Abstract] [Full Text] [Related]

  • 12. Sensitivity in detecting osseous lesions depends on anatomic localization: planar bone scintigraphy versus 18F PET.
    Schirrmeister H, Guhlmann A, Elsner K, Kotzerke J, Glatting G, Rentschler M, Neumaier B, Träger H, Nüssle K, Reske SN.
    J Nucl Med; 1999 Oct; 40(10):1623-9. PubMed ID: 10520701
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Intraindividual Comparison of 99mTc-Methylene Diphosphonate and Prostate-Specific Membrane Antigen Ligand 99mTc-MIP-1427 in Patients with Osseous Metastasized Prostate Cancer.
    Rathke H, Afshar-Oromieh A, Giesel FL, Kremer C, Flechsig P, Haufe S, Mier W, Holland-Letz T, De Bucourt M, Armor T, Babich JW, Haberkorn U, Kratochwil C.
    J Nucl Med; 2018 Sep; 59(9):1373-1379. PubMed ID: 29371410
    [Abstract] [Full Text] [Related]

  • 15. Bone scan as a stratification variable in advanced prostate cancer.
    Knudson G, Grinis G, Lopez-Majano V, Sansi P, Targonski P, Rubenstein M, Sharifi R, Guinan P.
    Cancer; 1991 Jul 15; 68(2):316-20. PubMed ID: 2070330
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Quantitative bone scintigraphy and 24-hour whole-body counting of 99mTc-methylene diphosphonate in patients with prostatic carcinoma.
    Sundkvist GM, Ahlgren L, Lilja B, Mattsson S.
    Nuklearmedizin; 1992 Oct 15; 31(5):178-81. PubMed ID: 1465355
    [Abstract] [Full Text] [Related]

  • 18. 99mTc-antigranulocyte bone marrow scintigraphy of breast and prostate skeletal metastases.
    Limouris GS, Voliotopoulos V, Stavraka A, Vlahos L.
    Anticancer Res; 1997 Oct 15; 17(3B):1615-8. PubMed ID: 9179204
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.